{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T18:54:37Z","timestamp":1785610477061,"version":"3.56.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20130455"],"award-info":[{"award-number":["BK20130455"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Innovation Cultivation Fund of Yangzhou University","award":["2013CXJ081"],"award-info":[{"award-number":["2013CXJ081"]}]},{"name":"Innovation Cultivation Fund of Yangzhou University","award":["2014CXJ059"],"award-info":[{"award-number":["2014CXJ059"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.jchromb.2017.05.003","type":"journal-article","created":{"date-parts":[[2017,5,10]],"date-time":"2017-05-10T01:17:56Z","timestamp":1494379076000},"page":"92-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Effects of breviscapine on amyloid beta 1-42 induced Alzheimer\u2019s disease mice: A HPLC-QTOF-MS based plasma metabonomics study"],"prefix":"10.1016","volume":"1057","author":[{"given":"Hongjun","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengying","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunliang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghai","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqun","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2017.05.003_bib0005","volume":"vol. I","year":"2015"},{"key":"10.1016\/j.jchromb.2017.05.003_bib0010","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1055\/s-0029-1185776","article-title":"Estrogenic and neuroprotective properties of scutellarin from Erigeron breviscapus: a drug against postmenopausal symptoms and Alzheimer's disease","volume":"75","author":"Zhu","year":"2009","journal-title":"Planta Med."},{"key":"10.1016\/j.jchromb.2017.05.003_bib0015","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jchromb.2017.05.003_bib0020","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1007\/s12035-013-8401-2","article-title":"Neuroprotective effects of resveratrol against A\u03b2 administration in rats are improved by lipid-core nanocapsules","volume":"47","author":"Frozza","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jchromb.2017.05.003_bib0025","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jns.2009.01.027","article-title":"Peoniflorin attenuates A\u03b2(1-42)-mediated neurotoxicity by regulating calcium homeostasis and ameliorating oxidative stress in hippocampus of rats","volume":"280","author":"Zhong","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jchromb.2017.05.003_bib0030","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.brainres.2011.10.020","article-title":"Genistein inhibits aggregation of exogenous amyloid-beta1-40 and alleviates astrogliosis in the hippocampus of rats","volume":"1429","author":"Bagheri","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.jchromb.2017.05.003_bib0035","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00213-011-2386-1","article-title":"Xanthoceraside attenuates amyloid \u03b2 peptide25\u201335-induced learning and memory impairments in mice","volume":"219","author":"Lu","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jchromb.2017.05.003_bib0040","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3233\/JAD-2012-111979","article-title":"A\u03b225-35 injection into the temporal cortex induces chronic inflammation that contributes to neurodegeneration and spatial memory impairment in rats","volume":"30","author":"Diaz","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jchromb.2017.05.003_bib0045","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3233\/JAD-130023","article-title":"1H NMR metabolomic signatures in five brain regions of the A\u03b2PPswe Tg2576 mouse model of Alzheimer's disease at four ages","volume":"39","author":"Lalande","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jchromb.2017.05.003_bib0050","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.neuint.2010.04.001","article-title":"A metabolomic study of the CRND8 transgenic mouse model of Alzheimer's disease","volume":"56","author":"Salek","year":"2010","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.jchromb.2017.05.003_bib0055","doi-asserted-by":"crossref","first-page":"764","DOI":"10.2174\/1567205013666160129095340","article-title":"Urinary metabolomics reveals alterations of aromatic amino acid metabolism of Alzheimer's disease in the transgenic CRND8 mice","volume":"13","author":"Tang","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.jchromb.2017.05.003_bib0060","doi-asserted-by":"crossref","first-page":"5903","DOI":"10.1021\/pr300666p","article-title":"Metabonomic profiling of TASTPM transgenic Alzheimer's disease mouse model","volume":"11","author":"Hu","year":"2012","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jchromb.2017.05.003_bib0065","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.neuroscience.2016.06.049","article-title":"Gender differences of peripheral plasma and liver metabolic profiling in APP\/PS1 transgenic AD mice","volume":"332","author":"Wu","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.jchromb.2017.05.003_bib0070","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1021\/pr5000895","article-title":"Plasma metabolite profiles of Alzheimer's disease and mild cognitive impairment","volume":"13","author":"Wang","year":"2014","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jchromb.2017.05.003_bib0075","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.clinbiochem.2010.04.072","article-title":"Plasma metabolic profiling of Alzheimer's disease by liquid chromatography\/mass spectrometry","volume":"43","author":"Li","year":"2010","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.jchromb.2017.05.003_bib0080","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.bbrc.2008.08.007","article-title":"A multi-metabolite analysis of serum by 1H NMR spectroscopy: early systemic signs of Alzheimer's disease","volume":"375","author":"Tukiainen","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jchromb.2017.05.003_bib0085","doi-asserted-by":"crossref","first-page":"e31501","DOI":"10.1371\/journal.pone.0031501","article-title":"Metabolite profiling of Alzheimer's disease cerebrospinal fluid","volume":"7","author":"Czech","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jchromb.2017.05.003_bib0090","doi-asserted-by":"crossref","first-page":"8532","DOI":"10.1021\/ac301243k","article-title":"Toward a predictive model of Alzheimer's disease progression using capillary electrophoresis-mass spectrometry metabolomics","volume":"84","author":"Ib\u00e1\u00f1ez","year":"2012","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2017.05.003_bib0095","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1021\/ac303163f","article-title":"Investigation of the human brain metabolome to identify potential markers for early diagnosis and therapeutic targets of Alzheimer's disease","volume":"85","author":"Graham","year":"2013","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2017.05.003_bib0100","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1002\/elps.201400544","article-title":"High throughput multiorgan metabolomics in the APP\/PS1 mouse model of Alzheimer's disease","volume":"36","author":"Gonz\u00e1lez-Dom\u00ednguez","year":"2015","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jchromb.2017.05.003_bib0105","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/elps.200800589","article-title":"A proposed metabolic strategy for monitoring disease progression in Alzheimer's disease","volume":"30","author":"Greenberg","year":"2009","journal-title":"Electrophoresis"},{"issue":"1016","key":"10.1016\/j.jchromb.2017.05.003_bib0110","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jchromb.2016.02.007","article-title":"Metabolomics approach to explore the effects of Kai-Xin-San on Alzheimer's disease using UPLC\/ESI-Q-TOF mass spectrometry","volume":"1015","author":"Chu","year":"2016","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2017.05.003_bib0115","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jpba.2015.07.007","article-title":"A UHPLC-TOF\/MS method based metabonomic study of total ginsenosides effects on Alzheimer disease mouse model","volume":"115","author":"Gong","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2017.05.003_bib0120","series-title":"The Mouse Brain in Stereotaxic Coorinates","author":"Paxinos","year":"2001"},{"key":"10.1016\/j.jchromb.2017.05.003_bib0125","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1021\/ac051495j","article-title":"Large-scale human metabolomics studies: a strategy for data (Pre-) processing and validation","volume":"78","author":"Bijlsma","year":"2006","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2017.05.003_bib0130","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.bbamem.2013.01.015","article-title":"Membrane fusion and vesicular transformation induced by Alzheimer\u2019s amyloid beta","volume":"1828","author":"Vestergaard","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jchromb.2017.05.003_bib0135","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neuroscience.2015.02.034","article-title":"Lysophosphatidylcholine increases the neurotoxicity of Alzheimer\u2019s amyloid \u03b21-42 peptide: role of oligomer formation","volume":"292","author":"Sheikh","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.jchromb.2017.05.003_bib0140","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1038\/tp.2011.55","article-title":"Metabolome in progression to Alzheimer's disease","volume":"1","author":"Ore\u0161i\u010d","year":"2011","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jchromb.2017.05.003_bib0145","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1476-511X-12-68","article-title":"Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated human amyloid precursor protein\/tau for Alzheimer\u2019s disease","volume":"12","author":"Tajima","year":"2013","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.jchromb.2017.05.003_bib0150","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1074\/jbc.M111.274142","article-title":"Comparative lipidomic analysis of mouse and human brain with Alzheimer disease","volume":"287","author":"Chan","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jchromb.2017.05.003_bib0155","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jprot.2014.01.014","article-title":"Combination of metabolomic and phospholipid-profiling approaches for the study of Alzheimer\u2019s disease","volume":"104","author":"Gonz\u00e1lez-Dom\u00ednguez","year":"2014","journal-title":"J. Proteomics"},{"key":"10.1016\/j.jchromb.2017.05.003_bib0160","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jgr.2015.04.006","article-title":"A UPLC\/MS-based metabolomics investigation of the protective effect of ginsenosides Rg1 and Rg2 in mice with Alzheimer\u2019s disease","volume":"40","author":"Li","year":"2016","journal-title":"J. Ginseng Res."},{"key":"10.1016\/j.jchromb.2017.05.003_bib0165","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.neurobiolaging.2013.08.001","article-title":"Evidence of altered phosphatidylcholine metabolism in Alzheimer\u2019s disease","volume":"35","author":"Whiley","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jchromb.2017.05.003_bib0170","doi-asserted-by":"crossref","first-page":"7713","DOI":"10.1016\/j.chroma.2011.07.073","article-title":"From brain to food: analysis of phosphatidylcholins, lyso-phosphatidylcholins and phosphatidylcholin-plasmalogens derivates in Alzheimer\u2019s disease human post mortem brains and mice model via mass spectrometry","volume":"1218","author":"Grimm","year":"2011","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2017.05.003_bib0175","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00702-003-0007-9","article-title":"Decreased lysophosphatidylcholine\/phosphatidylcholine ratio in cerebrospinal fluid in Alzheimer\u2019s disease","volume":"110","author":"Mulder","year":"2003","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.jchromb.2017.05.003_bib0180","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1016\/j.bbamem.2008.07.027","article-title":"Amyloid-beta peptide induces temporal membrane biphasic changes in astrocytes through cytosolic phospholipase A2","volume":"1778","author":"Hicks","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jchromb.2017.05.003_bib0185","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4161\/cam.3.1.7402","article-title":"Oxidative stress in Alzheimer disease","volume":"3","author":"Gella","year":"2009","journal-title":"Cell Adh. Migr."},{"key":"10.1016\/j.jchromb.2017.05.003_bib0190","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s007020070051","article-title":"Membrane breakdown in acute and chronic neurodegeneration: focus on choline-containing phospholipids","volume":"107","author":"Klein","year":"2000","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.jchromb.2017.05.003_bib0195","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1046\/j.1471-4159.1998.70020786.x","article-title":"Phospholipid-metabolizing enzymes in Alzheimer\u2019s disease: increased lysophospholipid acyltransferase activity and decreased phospholipase A2 activity","volume":"70","author":"Ross","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jchromb.2017.05.003_bib0200","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000107144","article-title":"Elevated activities of lipases and lysophospholipase in Alzheimer\u2019s disease","volume":"1","author":"Farooqui","year":"1990","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.jchromb.2017.05.003_bib0205","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/rcm.7241","article-title":"Lipidomic analysis of p-chlorophenylalanine-treated mice using continuous-flow two-dimensional liquid chromatography\/quadrupole time-of-flight mass spectrometry","volume":"29","author":"Weng","year":"2015","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jchromb.2017.05.003_bib0210","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1474-9726.2012.00845.x","article-title":"High tryptophan diet reduces CA1 intraneuronal \u03b2-amyloid in the triple transgenic mouse model of Alzheimer\u2019s disease","volume":"11","author":"Noristani","year":"2012","journal-title":"Aging Cell"},{"key":"10.1016\/j.jchromb.2017.05.003_bib0215","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.lfs.2011.12.022","article-title":"Hypercholesterolemia accelerates intraneuronal accumulation of A\u03b2 oligomers resulting in memory impairment in Alzheimer\u2019s disease model mice","volume":"91","author":"Umeda","year":"2012","journal-title":"Life Sci."},{"key":"10.1016\/j.jchromb.2017.05.003_bib0220","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/nbdi.2000.0304","article-title":"Hypercholesterolemia accelerates the Alzheimer\u2019s amyloid pathology in a transgenic mouse model","volume":"7","author":"Refolo","year":"2000","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jchromb.2017.05.003_bib0225","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1073\/pnas.081620098","article-title":"Simvastatin strongly reduces levels of Alzheimer\u2019s disease \u03b2-amyloid peptides A\u03b242 and A\u03b240 in vitro and in vivo","volume":"98","author":"Fassbender","year":"2001","journal-title":"PNAS"},{"key":"10.1016\/j.jchromb.2017.05.003_bib0230","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1006\/nbdi.2001.0422","article-title":"A cholesterol-lowering drug reduces \u03b2-amyloid pathology in a transgenic mouse model of Alzheimer\u2019s disease","volume":"8","author":"Refolo","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jchromb.2017.05.003_bib0235","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1055\/s-0029-1185539","article-title":"Suppression of diet-induced hypercholesterolemia by scutellarin in rats","volume":"75","author":"Li","year":"2009","journal-title":"Planta Med."},{"key":"10.1016\/j.jchromb.2017.05.003_bib0240","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1248\/bpb.30.1308","article-title":"Isolation and identification of ten metabolites of breviscapine in rat urine","volume":"30","author":"Xia","year":"2007","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jchromb.2017.05.003_bib0245","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jchromb.2014.06.013","article-title":"Simultaneous determination of three glucuronide conjugates of scutellarein in rat plasma by LC\u2013MS\/MS for pharmacokinetic study of breviscapine","volume":"965","author":"Wang","year":"2014","journal-title":"J. Chromatogr. B"}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023216314878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023216314878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T23:51:23Z","timestamp":1569282683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023216314878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":49,"alternative-id":["S1570023216314878"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2017.05.003","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of breviscapine on amyloid beta 1-42 induced Alzheimer\u2019s disease mice: A HPLC-QTOF-MS based plasma metabonomics study","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2017.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}